CYP27A1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CYP27A1 monoclonal antibodies for research focused on understanding this critical enzyme. CYP27A1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP27A1, or cytochrome P450 27A1, is an essential enzyme involved in the metabolism of cholesterol and bile acids, playing a significant role in lipid homeostasis and cellular signaling. CYP27A1 function is crucial for maintaining cholesterol levels and preventing the accumulation of toxic metabolites, which can lead to various diseases, including atherosclerosis and neurodegenerative disorders. Understanding CYP27A1 activity provides valuable insights into cholesterol metabolism and its impact on human health. Research utilizing CYP27A1 monoclonal antibodies has revealed important mechanisms in lipid regulation and cellular function. Investigating CYP27A1 expression patterns helps identify potential therapeutic targets for metabolic disorders. Current studies continue to uncover new roles for CYP27A1 in both normal physiology and disease states. Santa Cruz Biotechnology monoclonal antibodies for CYP27A1 enable researchers worldwide to advance our understanding of cholesterol metabolism and its implications in human health.